医師調剤コスメシューティカルの世界市場：製品タイプ別、用途別、地域別規模および予測

医師調剤コスメシューティカルの市場規模と予測

医師調剤コスメシューティカル市場規模は、2024年に95億9,000万米ドルと評価され、2026～2032年にかけてCAGR 8.98%で成長し、2032年には190億8,000万米ドルに達すると予測されます。

美容の本質と展望の高まり、アンチエイジングに対する意識の高まりが、医師派遣コスメシューティカル市場の成長を促すと考えられます。医師調剤コスメシューティカルの安全性と有効性に関する知識の増加、加齢によるシミやニキビ跡の減少など、多様な肌トラブルに対する特定の解決策を求めるユーザーの気質の高まりなどの要因が、予測期間中に医師調剤コスメシューティカル市場の成長をさらに促進すると予想されます。

医師調剤コスメシューティカルの世界市場定義

コスメシューティカルは、薬効成分を含む化粧品です。これらの製品は法的検証を必要としないです。医師調剤コスメシューティカルとは、医療的に指示された事業を通じてのみ入手可能な化粧品であり、角質層下の皮膚に実際の生物学的作用をもたらすことを目的としています。これらのコスメシューティカルを配合することを選択する医師は多く、その診療または専門は皮膚の健康に関与しています。医師調剤コスメシューティカル製品には、スキンケア、アイケア、ヘアケア製品などがあります。

これらの製品は、老化の兆候、感染症、その他の個人的な外観を対象に特別に設計されています。医師調剤コスメシューティカルとは、医療的に指示されたビジネスを通じてのみ入手可能な製品を指し、角質層下の皮膚に実際の生物学的作用をもたらすことを目的としています。医師調剤コスメシューティカルには、皮膚科医、毛髪科医、美容外科医、その他の医療関係者から発表された薬用美容製品が含まれます。

医師調剤コスメシューティカルの世界市場概要

美容と外見に関する重要性の高まりとアンチエイジングに対する意識の高まりが、医師調剤コスメシューティカルの世界市場の成長を促進すると予想される主要因です。さらに、医師調剤コスメシューティカルの安全性と有効性に関する意識の高まりと新製品の発売も、世界市場の成長に寄与するその他の要因です。

さらに、医師調剤コスメシューティカルは、通常のOTC製品よりも皮膚に深く浸透するオーダーメイド製品です。

これらの製品は深く浸透するため、早期により良い結果をもたらし、これがこの市場の成長の主要因となっています。フィジシャンラインのほとんどは、医師、皮膚の専門家、科学者によって設計・調合されており、彼らは長年にわたって成分を調査し、自分たちのクリニックでそれらを実践して、意図した対象を治療しています。加えて、美容と外見の重要性の高まり、アンチエイジングに対する意識の高まり、医師調剤コスメシューティカルの安全性と有効性に対する意識の高まりも、市場成長の要因となっています。

目次

第1章 医師調剤コスメシューティカルの世界市場導入

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 医師調剤コスメシューティカルの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 医師調剤コスメシューティカルの世界市場：製品タイプ別

• 概要
• スキンケア製品
• ヘアケア製品
• アイケア製品

第6章 医師調剤コスメシューティカルの世界市場：用途別

• 概要
• 病院薬局
• 小売薬局
• オンライン販売

第7章 医師調剤コスメシューティカルの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他の欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他のアジア太平洋
• その他
  • ラテンアメリカ
  • 中東・アフリカ

第8章 世界の医師調剤コスメシューティカル市場の競合情勢

• 概要
• 各社の市場ランキング
• 主要開発戦略

第9章 企業プロファイル

• Johnson & Johnson
• Allergan plc
• Procter & Gamble Co.
• Jan Marini Skin Research, Inc.
• L'Oreal S.A.
• Bausch Health Companies Inc.
• Unilever plc
• ZO Skin Health Inc.
• Obagi Cosmeceuticals LLC
• Merz Pharma

第10章 主要開発

• 製品上市/開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第11章 付録

• 関連調査

Physician Dispensed Cosmeceuticals Market Size And Forecast

Physician Dispensed Cosmeceuticals Market size was valued at USD 9.59 Billion in 2024 and is projected to reach USD 19.08 Billion by 2032, growing at a CAGR of 8.98% from 2026 to 2032.

The growing of essence of beauty and outlook, and the increasing consciousness about anti-aging, will encourage the growth of the Physician Dispensed Cosmeceuticals Market. Factors such as the growing knowledge about the security and effectiveness of Physician Dispensed Cosmeceuticals and escalating disposition of users towards a certain solution to diverse skin problems about age spot or acne spot reduction are anticipated to further propel the growth of the Physician Dispensed Cosmeceuticals Market during the forecast period.

Global Physician Dispensed Cosmeceuticals Market Definition

Cosmeceuticals are cosmetics that consist of medicinal properties. These products do not require any legal verification. Physician Dispensed Cosmeceuticals are cosmetic products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. There are many physicians who choose to dispense these cosmeceuticals whose practices or specialties involve skin health. Physician Dispensed Cosmeceuticals involve the products such as skin care, eye care, hair care products, and others.

These products are specially designed to target the signs of aging, infections, and other personal appearances. Physician Dispensed Cosmeceuticals refer to products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. Physician Dispensed Cosmeceuticals include medicated aesthetic products referred by dermatologists, trichologists, cosmetic surgeons, and allied medical professionals.

Global Physician Dispensed Cosmeceuticals Market Overview

Rising importance regarding beauty and appearance and increasing awareness about anti-aging are the primary factors expected to fuel the growth of the Global Physician Dispensed Cosmeceuticals Market. Furthermore, increasing awareness regarding the safety and efficacy of physician-dispensed cosmeceuticals and new product launches are other factors contributing to the growth of the global market.

Moreover, Physician Dispensed Cosmeceuticals are custom-made products that penetrate deeper into the skin than normal OTC products.

As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market. Most Physician lines are designed and formulated by physicians, skin professionals, and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, the increasing importance of beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market.

Global Physician Dispensed Cosmeceuticals Market: Segmentation Analysis

The Global Physician Dispensed Cosmeceuticals Market is segmented on the basis of Product Type, Application, and Geography.

Physician Dispensed Cosmeceuticals Market, By Product Type

• Skin care products
• Hair care products
• Eye care products

Based on Product Type, the market is bifurcated into Skin care products, Hair care products, and Eye care products. The skincare products segment accounted for a prominent share of the Global Physician Dispensed Cosmeceuticals Market in 2022, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions. Increasing awareness about personal maintenance among the geriatric population and changing attitudes of middle-aged and geriatric populations in developing countries have fuelled the demand for cosmeceuticals in order to eliminate the outward signs of aging.

Physician Dispensed Cosmeceuticals Market, By Application

• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Based on the Application, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Online Sales.

Physician Dispensed Cosmeceuticals Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
• On the basis of Regional Analysis, The Global Physician Dispensed Cosmeceuticals Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific region is expected to grow significantly over the forecast period. A growing preference to behold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific.

Key Players

The "Global Physician Dispensed Cosmeceuticals Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Johnson & Johnson, Allergan plc, Procter & Gamble Co., Jan Marini Skin Research, Inc., L'Oreal S.A., Bausch Health Companies Inc., Unilever plc, ZO Skin Health Inc., Merz Pharma, and Obagi Cosmeceuticals LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Key Developments

• In 2019, Galderma, a leading player in the physician-dispensed cosmeceuticals market, announced a partnership with Colorescience, a cosmetics company that specializes in mineral-based sunscreens and other skincare products. The partnership aimed to offer a wider range of skincare options to patients and consumers.
• In October 2021, Huons Biopharma signed a contract worth 97.2 billion won with German-based pharmaceutical company Haemato Pharm to distribute its botulinum toxin product exclusively to the European market. Thus, such instances show an increase in demand for physician-dispensed cosmeceuticals, which is ultimately driving market growth.
• Ace Matrix Analysis
• The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into Active, Cutting Edge, Emerging, and Innovators categories.
• Market Attractiveness
• The image of market attractiveness provided further helps to get information about the region leading in the Global Physician Dispensed Cosmeceuticals Market. We cover the major impacting factors driving the industry growth in the given region.
• Porter's Five Forces
• The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Physician Dispensed Cosmeceuticals Market, gauge the attractiveness of a particular sector, and assess investment possibilities.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Skin care products
• 5.3 Hair care products
• 5.4 Eye care products

6 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hospital Pharmacy
• 6.3 Retail Pharmacy
• 6.4 Online Sales

7 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East and Africa

8 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Johnson & Johnson
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Allergan plc
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Procter & Gamble Co.
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Jan Marini Skin Research, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 L'Oreal S.A.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Bausch Health Companies Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Unilever plc
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 ZO Skin Health Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Obagi Cosmeceuticals LLC
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 Merz Pharma
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research